Effects of scopolamine on visual evoked potentials in aging and dementia

Patty G Ray, K. J. Meador, D. W. Loring, Anthony M Murro, J. J. Buccafusco, X. H. Yang, E. Y. Zamrini, W. O. Thompson, E. E. Thompson

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The unusual combination of a normal pattern reversal VEP and a delayed flash VEP has been reported in patients with dementia of Alzheimer's type (DAT). Hyoscine hydrobromide has been reported to produce a similar VEP abnormality in young, healthy subjects. In the present study, we assessed the relative sensitivity of DAT patients and healthy young, middle-aged and elderly subjects to temporary cholinergic blockade. We report VEP latency values following 3 doses of scopolamine and after a peripheral anticholinergic agent. Falsh P2 latency was not significantly slower in DAT patients than in the healthy elderly. Scopolamine increased P2 latency in the young controls but did not affect any other group. The pattern reversal P100 was normal in DAT, and a significant increase in latency occurred following scopolamine administration in both the control and patient groups.

Original languageEnglish (US)
Pages (from-to)347-351
Number of pages5
JournalElectroencephalography and Clinical Neurophysiology/ Evoked Potentials
Volume80
Issue number5
DOIs
StatePublished - Jan 1 1991

Fingerprint

Scopolamine Hydrobromide
Visual Evoked Potentials
Dementia
Alzheimer Disease
Cholinergic Antagonists
Cholinergic Agents
Healthy Volunteers
Control Groups

Keywords

  • Aging
  • Cholinergic blockade
  • Dementia
  • Scopolamine
  • Visual evoked potential

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Effects of scopolamine on visual evoked potentials in aging and dementia. / Ray, Patty G; Meador, K. J.; Loring, D. W.; Murro, Anthony M; Buccafusco, J. J.; Yang, X. H.; Zamrini, E. Y.; Thompson, W. O.; Thompson, E. E.

In: Electroencephalography and Clinical Neurophysiology/ Evoked Potentials, Vol. 80, No. 5, 01.01.1991, p. 347-351.

Research output: Contribution to journalArticle

Ray, PG, Meador, KJ, Loring, DW, Murro, AM, Buccafusco, JJ, Yang, XH, Zamrini, EY, Thompson, WO & Thompson, EE 1991, 'Effects of scopolamine on visual evoked potentials in aging and dementia', Electroencephalography and Clinical Neurophysiology/ Evoked Potentials, vol. 80, no. 5, pp. 347-351. https://doi.org/10.1016/0168-5597(91)90081-8
Ray, Patty G ; Meador, K. J. ; Loring, D. W. ; Murro, Anthony M ; Buccafusco, J. J. ; Yang, X. H. ; Zamrini, E. Y. ; Thompson, W. O. ; Thompson, E. E. / Effects of scopolamine on visual evoked potentials in aging and dementia. In: Electroencephalography and Clinical Neurophysiology/ Evoked Potentials. 1991 ; Vol. 80, No. 5. pp. 347-351.
@article{d9e8c66d6c6946118809512a295cb892,
title = "Effects of scopolamine on visual evoked potentials in aging and dementia",
abstract = "The unusual combination of a normal pattern reversal VEP and a delayed flash VEP has been reported in patients with dementia of Alzheimer's type (DAT). Hyoscine hydrobromide has been reported to produce a similar VEP abnormality in young, healthy subjects. In the present study, we assessed the relative sensitivity of DAT patients and healthy young, middle-aged and elderly subjects to temporary cholinergic blockade. We report VEP latency values following 3 doses of scopolamine and after a peripheral anticholinergic agent. Falsh P2 latency was not significantly slower in DAT patients than in the healthy elderly. Scopolamine increased P2 latency in the young controls but did not affect any other group. The pattern reversal P100 was normal in DAT, and a significant increase in latency occurred following scopolamine administration in both the control and patient groups.",
keywords = "Aging, Cholinergic blockade, Dementia, Scopolamine, Visual evoked potential",
author = "Ray, {Patty G} and Meador, {K. J.} and Loring, {D. W.} and Murro, {Anthony M} and Buccafusco, {J. J.} and Yang, {X. H.} and Zamrini, {E. Y.} and Thompson, {W. O.} and Thompson, {E. E.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0168-5597(91)90081-8",
language = "English (US)",
volume = "80",
pages = "347--351",
journal = "Electroencephalography and Clinical Neurophysiology - Evoked Potentials",
issn = "0168-5597",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Effects of scopolamine on visual evoked potentials in aging and dementia

AU - Ray, Patty G

AU - Meador, K. J.

AU - Loring, D. W.

AU - Murro, Anthony M

AU - Buccafusco, J. J.

AU - Yang, X. H.

AU - Zamrini, E. Y.

AU - Thompson, W. O.

AU - Thompson, E. E.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The unusual combination of a normal pattern reversal VEP and a delayed flash VEP has been reported in patients with dementia of Alzheimer's type (DAT). Hyoscine hydrobromide has been reported to produce a similar VEP abnormality in young, healthy subjects. In the present study, we assessed the relative sensitivity of DAT patients and healthy young, middle-aged and elderly subjects to temporary cholinergic blockade. We report VEP latency values following 3 doses of scopolamine and after a peripheral anticholinergic agent. Falsh P2 latency was not significantly slower in DAT patients than in the healthy elderly. Scopolamine increased P2 latency in the young controls but did not affect any other group. The pattern reversal P100 was normal in DAT, and a significant increase in latency occurred following scopolamine administration in both the control and patient groups.

AB - The unusual combination of a normal pattern reversal VEP and a delayed flash VEP has been reported in patients with dementia of Alzheimer's type (DAT). Hyoscine hydrobromide has been reported to produce a similar VEP abnormality in young, healthy subjects. In the present study, we assessed the relative sensitivity of DAT patients and healthy young, middle-aged and elderly subjects to temporary cholinergic blockade. We report VEP latency values following 3 doses of scopolamine and after a peripheral anticholinergic agent. Falsh P2 latency was not significantly slower in DAT patients than in the healthy elderly. Scopolamine increased P2 latency in the young controls but did not affect any other group. The pattern reversal P100 was normal in DAT, and a significant increase in latency occurred following scopolamine administration in both the control and patient groups.

KW - Aging

KW - Cholinergic blockade

KW - Dementia

KW - Scopolamine

KW - Visual evoked potential

UR - http://www.scopus.com/inward/record.url?scp=0025886127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025886127&partnerID=8YFLogxK

U2 - 10.1016/0168-5597(91)90081-8

DO - 10.1016/0168-5597(91)90081-8

M3 - Article

C2 - 1716558

AN - SCOPUS:0025886127

VL - 80

SP - 347

EP - 351

JO - Electroencephalography and Clinical Neurophysiology - Evoked Potentials

JF - Electroencephalography and Clinical Neurophysiology - Evoked Potentials

SN - 0168-5597

IS - 5

ER -